The spectrum effect in the evaluation of Cushing syndrome

Current Opinion in Endocrinology and Diabetes

Volumn 10, Issue 4, 2003, Pages 272-276

  Ayala, Alejandro R ^a,b   Ilias, Ioannis ^a   Nieman, Lynnette K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MSC 1583 ^*  (United States)

Author keywords

Bias; Cushing syndrome; Diagnosis; Spectrum

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANXIETY DISORDER; BODY MASS; CIGARETTE SMOKING; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; CULTURAL FACTOR; CUSHING SYNDROME; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEDICAL DECISION MAKING; MEDICAL PRACTICE; OBSESSIVE COMPULSIVE DISORDER; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; RELIABILITY; REPRODUCIBILITY; REVIEW; SEX DIFFERENCE; SLEEP DISORDER;

EID: 0242391975     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200308000-00008     Document Type: Review

References (32)

1. Mulherin SA, Miller WC: Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 2002, 137:598-602. This paper proposes the use of the term spectrum effect, rather than spectrum bias, and outlines strategies for using stratified sensitivity and specificity estimates, likelihood ratios, and receiver-operating characteristic curves.
2. Nierenberg AA, Feinstein AR: How to evaluate a diagnostic marker test: Lessons from the rise and fall of dexamethasone suppression test. JAMA 1988, 259:1699-1702.
3. Spitalnic S: Spectrum bias and clinical decision making. Hosp Phys 2001, 37:22-24.
4. Begg CB: Biases in the assessment of diagnostic tests. Stat Med 1987, 6:411-423.
5. Ransohff DF, Feinstein AR: Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978, 299:926-930.
6. Yanovski JA, Yanovski SZ, Cutler GBJ, et al.: Differences in the hypothalamic-pituitary-adrenal axis of black girls and white girls. J Pediatr 1996, 129:130-135.
7. Yanovski JA, Yanovski SZ, Harrington L, et al.: Differences in the hypothalamic-pituitary-adrenal axis of black and white men. Horm Res 1995, 44:208-212.
8. Yanovski JA, Yanovski SZ, Gold PW, et al.: Differences in the hypothalamic-pituitary-adrenal axis of black and white women. J Clin Endocrinol Metab 1993, 77:536-541.
9. Nieman LK: Diagnostic tests for Cushing's syndrome. Ann NY Acad Sci 2002, 970:112-118. Concise review with an algorithm on establishing a diagnosis of Cushing syndrome.
10. Wood PJ, Barth JH, Freedman DB, et al.: Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome: Recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997, 34:222-229.
11. de Bos Kuil MJ, Endert E, Fliers E, et al: Establishment of reference values for endocrine tests. I: Cushing's syndrome. Neth J Med 1998, 53:153-163.
12. Newell-Price J, Trainer P, Besser M, et al.: The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998, 19:647-672.
13. Boscaro M, Barzon L, Sonino N: The diagnosis of Cushing's syndrome: Atypical presentations and laboratory shortcomings. Arch Intern Med 2000, 160:3045-3053.
14. Yanovski JA, Cutler GB Jr, Chrousos GP, et al.: Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993, 269:2232-2238.
15. Castro M, Elias PC, Quidute AR, et al.: Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 1999, 84:878-882.
16. Pikkarainen L, Alfthan H, Markkanen H, et al.: Midnight serum cortisol: comparison of healthy volunteers and hospitalized patients with Cushing's syndrome. Scand J Clin Lab Invest 2002, 62:357-360.
17. Papanicolaou DA, Yanovski JA, Cutler GBJ, et al.: A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998, 83:1163-1167.
18. Raff H, Findling JW: A physiologic approach to diagnosis of Cushing syndrome. Ann Int Med 2003, 138:980-991. Very recent tutorial on the diagnostic steps to be taken for the evaluation of patients with suspected Cushing syndrome.
19. Taylor RL, Grebe SK, Findling JW, et al.: Diagnosis of Cushings Syndrome with a Sensitive and Specific LC-MS/MS Method for Late Night Salivary Cortisol. Abstract P2-563. Presented at ENDO 2003: 85th Annual Meeting of the American Endocrine Society, June 19-22, 2003, Philadelphia, Pennsylvania.
20. Papanicolaou DA, Mullen N, Kyrou I, et al.: Nighttime salivary cortisol: A useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2002, 87:4515-4521.
21. Raff H, Raff JL, Findling JW: Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998, 83:2681-2686.
22. Putignano P, Dubini A, Toja P, et al.: Salivary cortisol measurement in normal-weight, obese and anorexic women: Comparison with plasma cortisol. Eur J Endocrinol 2001, 145:165-171.
23. Martinelli CE Jr, Sader SL, Oliveira EB, et al.: Salivary cortisol for screening of Cushing's syndrome in children. Clin Endocrinol (Oxf) 1999, 51:67-71.
24. Gafni RI, Papanicolaou DA, Nieman LK: Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents. J Pediatr 2000, 137:30-35.
25. Crapo L: Cushing's syndrome: A review of diagnostic tests. Metabolism 1979, 28:955-977.
26. Klee GG: Maximizing efficacy of endocrine tests: Importance of decision-focused testing strategies and appropriate patient preparation. Clin Chem 1999, 45:1323-1330.
27. Yanovski JA, Cutler GB Jr, Chrousos GP, et al.: The dexamethasone- suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. J Clin Endocrinol Metab 1998, 83:348-352.
28. Klose M, Kofoed-Enevoldsen A, Ostergaard Kristensen L: Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and -independent Cushing's syndrome. Scand J Clin Lab Invest 2002, 62:33-37. Concludes that in most patients with Cushing syndrome, a single, basal, morning ACTH level determination is sufficient to discriminate between ACTH-dependent and ACTH-independent Cushing syndrome.
29. Invitti C, Giraldi FP, De Martin M, et al.: Diagnosis and management of Cushing's syndrome: Results of an Italian multicentre study. J Clin Endocrinol Metab 1999, 84:440-448.
30. Magiakou MA, Mastorakos G, Oldfield EH, et al.: Cushing's syndrome in children and adolescents: Presentation, diagnosis, and therapy. N Engl J Med 1994, 331:629-636.
31. Pecori Giraldi F, Invitti C, Cavagnini F: Inferior petrosal sinus sampling ten years down the road. J Endocrinol Invest 2000, 23:325-327.
32. Bossuyt PM, Reitsma JB, Bruns DE, et al.: Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 2003, 49:1-6.